Fundz

Pneumowave Raises £7.5 Million Series A To Accelerate Clinical Validation And Regulatory Submission Of Respiratory Change Diagnosis And Monitoring Platform

PRIVATEJan 12, 2023

Amount Raised

£7.5 Million

Round Type

Series A

Financial ServicesHealth Care

Investors

NrchKing's College LondonUniversity Of GlasgowUniversity Of DundeeThairm BioScottish Investment PartnersLondonMark Bamforth Of Thairm BioAlba EquityEquity GapIigScottish EnterpriseScottish National Investment Bank

Description

Digital health company PneumoWave today announced the closing of £7.5 m Series A financing which will enable clinical validation and regulatory submission of its biosensor technology platform for remote wireless diagnosing and monitoring potentially fatal respiratory changes in high-risk patient groups. The round comprises £5.2 million equity from new investors Scottish National Investment Bank, alongside £2.3 million from existing investors Scottish Enterprise, IIG, Equity Gap, Alba Equity and London and Scottish Investment Partners. Boston based life science investor Mark Bamforth of Thairm Bio also joined the round as PneumoWave prepares to ramp up its US operations. PneumoWave's technology is being developed as part of an international research program in collaboration with the University of Dundee, University of Glasgow, King's College London, and NRCH and Department of Health in Victoria, Australia.

Quick answer

PneumoWave raised £7.5 Million in a Series A round, dated January 12, 2023. Investors: Nrch, King's College London, University Of Glasgow, University Of Dundee, Thairm Bio, Scottish Investment Partners, London and Mark Bamforth Of Thairm Bio.

How much did PneumoWave raise?
PneumoWave raised £7.5 Million in a Series A round on January 12, 2023.
Who invested in PneumoWave?
Nrch, King's College London, University Of Glasgow, University Of Dundee, Thairm Bio, Scottish Investment Partners, London and Mark Bamforth Of Thairm Bio are named as investors in this round.
What does PneumoWave do?
Medical device company: AI platform for real-time remote respiratory monitoring.

Source: Fundz verified event record.

Who else raised in Financial Services and Health Care around the same time

Companies in the same sectors as PneumoWave that raised within 45 days of this round, from Fundz verified event records.

  • Streamex Corp. raised $603K (Seed) on February 8, 2023.
  • Streamex Corp. raised $2M (Seed) on February 3, 2023.
  • Stride raised $750K (Seed) on February 3, 2023.
  • Streamex Corp. raised $234K (Seed) on January 25, 2023.
  • Streamex Corp. raised $1.9M (Seed) on January 23, 2023.
  • Resilience raised an undisclosed amount on January 10, 2023.

Who to call at PneumoWave, and when

A new round usually means PneumoWave is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PneumoWave raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PneumoWave, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PneumoWave. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PneumoWave

About

Medical device company: AI platform for real-time remote respiratory monitoring. Patents pending in US and UK. Read more at our website.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PneumoWave raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for PneumoWave's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

PneumoWave raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.